Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Bio-Rad Laboratories, Inc. (BIO)

NYSE

$377.95

$+9.45

(+2.56%)

Pre-Market

Bio-Rad Laboratories, Inc. (BIO) Live Price Chart

Last updated: ⁦2026-09-16 09:06:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Bio-Rad Laboratories, Inc. (BIO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $377.95, with a market capitalisation of $9.85B and a P/E ratio of 45.45. Over the past 52 weeks, its price has ranged from $236.73 to $396.23. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.85B
Open	$366.33
Day's High	$832.70
Day's Low	$46.54
Previous Close	$368.55
Volume	461.32K
Average Volume	294.99K
P/E Ratio	45.45
52-Week High	$396.23
52-Week Low	$236.73
Dividend Yield	--
Earnings Date	--

Bio-Rad Laboratories, Inc. (BIO) Pre-Market Stock Price

Bio-Rad Laboratories, Inc. (BIO) is trading at $368.79 in pre-market trading as of 2026-09-15 23:31:00, up 0.06% ($0.24) from the previous close of $368.55

Pre-market trading shows how investors are pricing BIO before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Bio-Rad Laboratories, Inc. (BIO) 7-Day Stock Price Change

Over the past seven days, Bio-Rad Laboratories, Inc. (BIO) moved from $386.11 to $377.95, representing a decline of 2.11% ($8.16).

The stock traded between $365.66 and $390.73 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 274.30 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

BIO 52-Week Price Position

Position in Range: 88.5%

52W Low$236.73

52W High$396.23

BIO is currently trading at $377.95, placing it 88.5% of the way from its 52-week low of $236.73 to its 52-week high of $396.23. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bio-Rad Laboratories, Inc. (BIO)?

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Laboratories, Inc. Information

Industry	LABORATORY ANALYTICAL INSTRUMENTS
Employees	7450
Exchange	NYSE
Company Website	https://www.bio-rad.com

How to Buy Bio-Rad Laboratories, Inc. (BIO) Stock on MEXC

Eligible investors can buy real shares of Bio-Rad Laboratories, Inc. (BIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BIO and Place Your Order

Open the RealStocks trading page and search for BIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bio-Rad Laboratories, Inc. (BIO) stock price today?

Bio-Rad Laboratories, Inc. (BIO) is currently trading at $ 377.95, up 2.55% ($9.40) from the previous close of $ 368.55. Intraday prices update in real time during regular trading hours.

2.Is BIO stock going up or down today?

As of 2026-09-15 23:31:00, BIO is trading at $ 377.95, up 2.55% ($9.40) from its previous close of $ 368.55. The stock has traded between $ 46.54 and $ 832.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is BIO pre-market price?

As of 2026-09-15 23:31:00, BIO is trading at $ 368.79 in pre-market trading, up 0.06% ($0.24) from the previous close of $ 368.55. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BIO after-hours price?

As of 2026-09-15 23:31:00, BIO is trading at $ 377.98 in after-hours trading, up 2.56% ($9.43) from the regular-session close of $ 368.55. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BIO stock trading now?

BIO trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BIO sit relative to its 52-week high and low?

Over the past 52 weeks, BIO has traded between a low of $ 236.73 and a high of $ 396.23. At $ 377.95, the stock is positioned 88.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bio-Rad Laboratories, Inc. in?

Bio-Rad Laboratories, Inc. (BIO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bio-Rad Laboratories, Inc.'s market capitalisation and where is it listed?

Bio-Rad Laboratories, Inc. is listed on the NYSE exchange with a market capitalisation of $ 9.85B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BIO valued in terms of P/E ratio and EPS?

BIO trades at a P/E ratio of 45.45, based on trailing-twelve-month EPS of $ 8.32. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bio-Rad Laboratories, Inc. pay a dividend?

Bio-Rad Laboratories, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.